T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 27.36 CNY 1.41% Market Closed
Market Cap: 2.2B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Tongling Jieya Biologic Technology Co Ltd

Wall Street analysts forecast Tongling Jieya Biologic Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tongling Jieya Biologic Technology Co Ltd is 35.7 CNY with a low forecast of 35.35 CNY and a high forecast of 36.75 CNY.

Lowest
Price Target
35.35 CNY
29% Upside
Average
Price Target
35.7 CNY
30% Upside
Highest
Price Target
36.75 CNY
34% Upside
Tongling Jieya Biologic Technology Co Ltd Competitors:
Price Targets
4967
Kobayashi Pharmaceutical Co Ltd
0% Downside
090430
AmorePacific Corp
49% Upside
300740
SYoung Group Co Ltd
18% Upside
IPAR
Inter Parfums Inc
30% Upside
4190
Jourdeness Group Ltd
201% Upside
4922
Kose Corp
18% Upside
W7L
Warpaint London PLC
28% Upside
051900
LG H&H Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Tongling Jieya Biologic Technology Co Ltd

For the last 4 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's revenue is 22%. The projected CAGR for the next 2 years is 16%.

22%
Past Growth
16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tongling Jieya Biologic Technology Co Ltd

For the last 4 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's operating income is 9%. The projected CAGR for the next 2 years is 34%.

9%
Past Growth
34%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Tongling Jieya Biologic Technology Co Ltd

For the last 4 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's net income is 14%. The projected CAGR for the next 2 years is 17%.

14%
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tongling Jieya Biologic Technology Co Ltd's stock price target?
Price Target
35.7 CNY

According to Wall Street analysts, the average 1-year price target for Tongling Jieya Biologic Technology Co Ltd is 35.7 CNY with a low forecast of 35.35 CNY and a high forecast of 36.75 CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Revenue forecast?
Projected CAGR
16%

For the last 4 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's revenue is 22%. The projected CAGR for the next 2 years is 16%.

What is Tongling Jieya Biologic Technology Co Ltd's Operating Income forecast?
Projected CAGR
34%

For the last 4 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's operating income is 9%. The projected CAGR for the next 2 years is 34%.

What is Tongling Jieya Biologic Technology Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 4 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's net income is 14%. The projected CAGR for the next 2 years is 17%.

Back to Top